Regenerative · BMP-2-inspired osteogenic research peptide
P24 BMP-2-derived peptide
Also known as P24; BMP-2-derived P24
A BMP-2-inspired peptide designation used in scaffold research, with activity dependent on the exact sequence and presentation.
- Length
- 24 amino acids in commonly described constructs; verify the supplied sequence
- Half-life
- Not well characterised
- Mechanism
- P24 is designed to reproduce selected biological features of a BMP-2-derived region in a short synthetic construct. BMP-associated signalling, including SMAD1/5/9 phosphorylation, is investigated, but direct receptor affinity and equivalence to intact BMP-2 are not established by the name alone.
- Studied in
- P24 constructs are studied in osteogenic cell cultures, peptide-functionalised scaffolds and animal bone-defect models.
About P24 BMP-2-derived peptide
P24 generally denotes a short synthetic construct derived from a biologically active region of bone morphogenetic protein 2, often incorporating additional residues for material interaction. Published scaffold studies include a phosphorylated N-terminal serine and an acidic terminal extension, so the label should not be treated as a complete chemical specification. The concept arose from efforts to retain selected BMP-associated cellular signals in smaller, more readily modified peptides rather than reproduce the intact dimeric growth factor.
Intact BMP-2 signals through complexes of type I and type II serine/threonine kinase receptors, with downstream SMAD1/5/9 activation. For P24, investigators typically assess pathway-associated readouts, alkaline phosphatase activity, osteogenic gene expression and matrix mineralisation in defined culture systems. These endpoints do not independently demonstrate direct receptor binding. Scaffold composition, phosphate-containing modifications and peptide retention can influence results, making sequence verification and material-matched controls particularly important when comparing reports that use the same P24 designation.
Laboratory notes
- Verify the complete sequence, residue count, phosphorylation state and terminal modifications before matching the product to a publication.
- For scaffold experiments, measure peptide incorporation and release separately; acidic extensions and phosphorylation can alter mineral binding.
- Combine pathway readouts with receptor-blocking controls, and include cell-free material controls in mineralisation assays.
Storage and reconstitution basics: storage guide.
Questions about P24 BMP-2-derived peptide
Is P24 chemically identical across publications?
Not necessarily. The designation can conceal differences in extensions or phosphorylation, so the reported sequence and modification pattern must be checked.
Can BMP-2 receptor specificity be assigned directly to P24?
No. Intact BMP-2 receptor biology provides context, but P24-specific receptor binding and selectivity require experimental confirmation.
Why are cell-free scaffold controls useful?
Mineral-containing or phosphate-binding materials can generate mineralisation-associated signals without a cellular response, potentially confounding endpoint assays.
Is P24 BMP-2-derived peptide for human use?
No. It is supplied strictly for in-vitro laboratory research and is not for human or animal consumption.
Related research peptides
All products are sold for laboratory research use only. Not for human consumption, not a medicine, not for diagnosing, treating or preventing any condition.